Summary
In a group of 110 dialysis patients, 21% had anti-HCV antibodies. Statistical differences were noted according to method and duration of dialysis as well as the presence of further risk factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
A. M. Couroŭcé et al (1990) Antibodies to hepatitis C virus in haemodialysis patients. Abst. 395, International Symposium on viral hepatitis and liver disease. Houston, Texas, April 4–8, 1990
U. Schlipköter et al (1990) Prevalence of anti-HCV in Haemodialysis patients in southern Germany. Abst. 397, International Symposium on viral hepatitis and liver disease. Houston, Texas, April 4–8, 1990
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag
About this paper
Cite this paper
Pizzaferri, P., Padrini, D., Viale, P., Fontana, F., Poisetti, G.P., Alberici, F. (1992). Hepatitis C virus (HCV) infection in the Piacenza dialysis center. In: De Bac, C., Taliani, G., Gerlich, W.H. (eds) Chronically Evolving Viral Hepatitis. Archives of Virology, vol 4. Springer, Vienna. https://doi.org/10.1007/978-3-7091-5633-9_79
Download citation
DOI: https://doi.org/10.1007/978-3-7091-5633-9_79
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82350-7
Online ISBN: 978-3-7091-5633-9
eBook Packages: Springer Book Archive